This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Hannah Dry
Introduction
Hannah Dry is a notable inventor based in Waltham, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of B-cell malignancies. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Hannah Dry holds 1 patent for her invention titled "Therapeutic combinations of acalabrutinib and capivasertib to treat B-cell malignancies." This patent focuses on the therapeutic combinations of acalabrutinib and capivasertib, or their pharmaceutically acceptable salts, aimed at treating, preventing, partially alleviating, or ameliorating B-cell malignancies, such as non-Hodgkin's lymphoma. The patent also encompasses pharmaceutical compositions and kits that include these compounds.
Career Highlights
Hannah Dry is currently associated with AstraZeneca AB, where she continues to innovate and contribute to the pharmaceutical industry. Her work has the potential to significantly impact the treatment landscape for patients suffering from B-cell malignancies.
Collaborations
Hannah has collaborated with esteemed colleagues, including Andrew Bloecher and Jerome Mettetal, to further her research and development efforts. These collaborations enhance the quality and reach of her innovative work.
Conclusion
Hannah Dry's contributions to the field of pharmaceuticals exemplify the impact of innovation in medicine. Her dedication to developing effective treatments for B-cell malignancies showcases her role as a leading inventor in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile